Data as of 11:56am ET
| -0.49 / -2.71%|
The 6 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 22.86, with a high estimate of 61.25 and a low estimate of 14.91. The median estimate represents a +29.97% increase from the last price of 17.59.
The current consensus among 7 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.